AMENDMENT NO. 1 TO FOUNDER COMMON STOCK PURCHASE AGREEMENTFounder Common Stock Purchase Agreement • June 12th, 2015 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
This Amendment No. 1 to Founder Common Stock Purchase Agreement (this “Amendment”) is made as of May 4, 2015, by and between Viking Therapeutics, Inc., a Delaware corporation (the “Company”), and Brian Lian, Ph.D. (“Purchaser”).
AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 12th, 2015 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
This Amendment No. 1 to Common Stock Purchase Agreement (this “Amendment”) is made as of May 4, 2015, by and between Viking Therapeutics, Inc., a Delaware corporation (the “Company”), and Brian Lian, Ph.D. (“Purchaser”).
AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • June 12th, 2015 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
This Amendment No. 1 to Common Stock Purchase Agreement (this “Amendment”) is made as of May 4, 2015, by and between Viking Therapeutics, Inc., a Delaware corporation (the “Company”), and Rochelle Hanley, M.D. (“Purchaser”).
AMENDED AND RESTATED STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • June 12th, 2015 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED STOCK REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of April 28, 2015, by and between Viking Therapeutics, Inc., a Delaware corporation (the “Company”), and the individuals listed on EXHIBIT A attached hereto (each, a “Seller” and, collectively, the “Sellers”). Each of the Company and each Seller shall be referred to herein, individually, as a “Party”, and the Company and such Sellers shall be referred to herein, collectively, as the “Parties.”
